HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer
暂无分享,去创建一个
W. Isaacs | C. Ewing | D. McDonnell | J. Norris | G. Torga | Kideok Jin | Dorhyun Johng
[1] A. Jemal,et al. Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.
[2] R. Bhanvadia,et al. HOXB13 mutations and binding partners in prostate development and cancer: Function, clinical significance, and future directions , 2017, Genes & diseases.
[3] I. Inoue,et al. Germline Variants of Prostate Cancer in Japanese Families , 2016, PloS one.
[4] R. Mann,et al. To Be Specific or Not: The Critical Relationship Between Hox And TALE Proteins. , 2016, Trends in genetics : TIG.
[5] G. Parmigiani,et al. Familial Risk and Heritability of Cancer Among Twins in Nordic Countries. , 2016, JAMA.
[6] A. Imai,et al. Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy , 2016, International Journal of Clinical Oncology.
[7] A. Jolma,et al. DNA-dependent formation of transcription factor pairs alters their binding specificity , 2015, Nature.
[8] Henry W. Long,et al. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis , 2015, Nature Genetics.
[9] Jorge Oliveira,et al. Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients , 2015, PloS one.
[10] S. Thibodeau,et al. The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[11] K. Rajagopalan,et al. Cancer/Testis Antigen PAGE4, a Regulator of c-Jun Transactivation, Is Phosphorylated by Homeodomain-Interacting Protein Kinase 1, a Component of the Stress-Response Pathway , 2014, Biochemistry.
[12] Kai Zhang,et al. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding , 2014, Nature Genetics.
[13] R. Rezsohazy. Non‐transcriptional interactions of Hox proteins: Inventory, facts, and future directions , 2014, Developmental dynamics : an official publication of the American Association of Anatomists.
[14] H. Grönberg,et al. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk. , 2014, European urology.
[15] C. Greenwood,et al. The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial. , 2013, Carcinogenesis.
[16] J. Stanford,et al. HOXB13 mutations in a population‐based, case–control study of prostate cancer , 2013, The Prostate.
[17] Fátima Sánchez-Cabo,et al. Analysis of the DNA-binding profile and function of TALE homeoproteins reveals their specialization and specific interactions with Hox genes/proteins. , 2013, Cell reports.
[18] P. Jarzemski,et al. The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland , 2013, The Prostate.
[19] L. Aaltonen,et al. HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[20] Jianfeng Xu,et al. A novel Germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men , 2013, The Prostate.
[21] A. Whittemore,et al. HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG) , 2012, Human Genetics.
[22] J. Trachtenberg,et al. Association between germline HOXB13 G84E mutation and risk of prostate cancer. , 2012, Journal of the National Cancer Institute.
[23] Y. Lussier,et al. Deregulation of a Hox Protein Regulatory Network Spanning Prostate Cancer Initiation and Progression , 2012, Clinical Cancer Research.
[24] Joan P. Breyer,et al. Confirmation of the HOXB13 G84E Germline Mutation in Familial Prostate Cancer , 2012, Cancer Epidemiology, Biomarkers & Prevention.
[25] V. Morsch,et al. Cholinesterase activities and biochemical determinations in patients with prostate cancer: influence of Gleason score, treatment and bone metastasis. , 2012, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[26] J. Carpten,et al. Germline mutations in HOXB13 and prostate-cancer risk. , 2012, The New England journal of medicine.
[27] Joan P. Breyer,et al. Con fi rmation of the HOXB 13 G 84 E Germline Mutation in Familial Prostate Cancer , 2012 .
[28] C. Voelkel-Johnson. TRAIL-mediated signaling in prostate, bladder and renal cancer , 2011, Nature Reviews Urology.
[29] C. Jung,et al. HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling , 2010, Molecular Cancer.
[30] D. McDonnell,et al. The homeodomain protein HOXB13 regulates the cellular response to androgens. , 2009, Molecular cell.
[31] S. Balk,et al. Androgen receptor expression in prostate cancer cells is suppressed by activation of epidermal growth factor receptor and ErbB2. , 2009, Cancer research.
[32] R. Mann,et al. Chapter 3 Hox Specificity , 2009 .
[33] R. Mann,et al. Hox specificity unique roles for cofactors and collaborators. , 2009, Current topics in developmental biology.
[34] R. Humphries,et al. Unraveling the crucial roles of Meis1 in leukemogenesis and normal hematopoiesis. , 2007, Genes & development.
[35] C. Croce,et al. The E3 ubiquitin ligase Itch controls the protein stability of p63 , 2006, Proceedings of the National Academy of Sciences.
[36] G. Wang,et al. Persistent Transactivation by Meis1 Replaces Hox Function in Myeloid Leukemogenesis Models: Evidence for Co-Occupancy of Meis1-Pbx and Hox-Pbx Complexes on Promoters of Leukemia-Associated Genes , 2006, Molecular and Cellular Biology.
[37] W. Isaacs,et al. Phenotypic characterization of telomerase-immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines. , 2006, Experimental cell research.
[38] M. Hung,et al. Degradation of Mcl-1 by β-TrCP Mediates Glycogen Synthase Kinase 3-Induced Tumor Suppression and Chemosensitization , 2006, Molecular and Cellular Biology.
[39] R. Watson,et al. Targeting death receptors in bladder, prostate and renal cancer. , 2006, The Journal of urology.
[40] J. Innis,et al. Range of HOX/TALE superclass associations and protein domain requirements for HOXA13:MEIS interaction. , 2005, Developmental biology.
[41] M. Capecchi,et al. Hoxb13 is required for normal differentiation and secretory function of the ventral prostate , 2003, Development.
[42] W. Isaacs,et al. For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Pathological and Molecular Aspects of Prostate Cancer Prostate Cancer Ii , 2022 .
[43] C. Geula,et al. Neurobiology of butyrylcholinesterase , 2003, Nature Reviews Neuroscience.
[44] M. Featherstone. HOX proteins and their co-factors in transcriptional regulation , 2003 .
[45] J. Kaprio,et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. , 2000, The New England journal of medicine.
[46] J. Moskow,et al. AbdB-like Hox proteins stabilize DNA binding by the Meis1 homeodomain proteins , 1997, Molecular and cellular biology.
[47] N. Heintz,et al. Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity. , 1996, Development.
[48] J. Tyczynski,et al. Cancer in Poland. , 1993, Cancer detection and prevention.